Sie sind auf Seite 1von 3

Global OrthoBiologic Expands Its Operation Under the Name Global

REGENERATIVE Group (GRG)

Global OrthoBiologic has announced today that it will expand its operation under the name Global
REGENERATIVE Group (GRG) with headquarters to remain in Miami, Florida
(globalregenerative.group) and will consist of 4 divisions, which will operate independently –
Trade, Academy, Care and Finance.

Miami, FL, January 16, 2019 --(PR.com)-- Global OrthoBiologic, based in Miami, Florida, invests,
identifies, develops and markets ground-breaking medical technologies related to Regenerative Medicine
in the global market. Global OrthoBiologic is a privately-held medical technologies company specializing
in therapies that significantly enhance the body's natural healing ability. The company has developed
extensive experience in the most advanced medical device industries. In the past several years, the
emphasis has been focused exclusively on Regenerative Medicine and stem cell technologies, products,
and therapies.

The technologies for stem cells are cutting edge, safe, clean and do not use any additives, enzymes, or
require culturing or growing of cells. Global OrthoBiologic consults with medical technology companies
that are startups and/or companies looking to expand and grow their business. Global OrthoBiologic has
built a comprehensive network of experts in Europe, South America, Middle East, Asia, and Australia.
The company partners with recognized medical facilities worldwide for evidence-based clinical medicine.

Global OrthoBiologic has announced today that it will expand its operation under the name Global
REGENERATIVE Group (GRG) with headquarters to remain in Miami, Florida
(globalregenerative.group) and will consist of 4 divisions, which will operate independently - Trade,
Academy, Care and Finance. GRG will continue to offer its wide range of medical products in
Regenerative Medicine in various fields of medicine through its Global REGENERATIVE Trade and will
expand its operation with new technologies. Global REGENERATIVE Academy will concentrate on
Medical Science and Education. Global REGENERATIVE Care will focus exclusively on Medical
Tourism. Global REGENERATIVE Finance will identify medical advancements to improve patient
outcome and speed patient recovery.

Mihail Blagoev, Vice President commented, “We are excited to continue our growth and understanding in
the Regenerative Medicine Industry. Expanding our experience and dedication in medical science and
education through positioned events on different continents will give an opportunity to more and more
physicians and medical institutions to benefit from the Academy experts and to learn about the new
advancements in Regenerative Medicine. I believe that our continued expansion will benefit our trading
operation, and that will increase dramatically GRG revenue and value.”

Randy Beimel, President commented, “I would like to thank all of our partners that believed in us and our
capabilities. All of you are significant proof for our success today to become one of the leaders in the
Regenerative Medicine Industry. I would like to add that our Finance operation will be the key for our
future success; we have seen many great ideas that stayed for years in the physician's brains or at their

Page 1/3
PR.com Press Release Distribution Terms of Use
ORs. We would like to identify these great medical ideas to first of all help the patients heal faster, and
benefit GRG revenue and value.”

Page 2/3
PR.com Press Release Distribution Terms of Use
Contact Information:
Global OrthoBiologic Inc.
Randy Beimel
954-778-2581
Contact via Email
globalorthobiologic.com

Online Version of Press Release:


You can read the online version of this press release at: https://www.pr.com/press-release/774585

News Image:

Page 3/3
PR.com Press Release Distribution Terms of Use